Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. Biomarker testing is an opportunity to improve and optimize treatment – possibly avoiding unnecessary treatments and getting to the right treatment sooner. Through this targeted campaign, the LRG will focus on increasing our Patient Awareness and Education initiatives. Because of our assertive focus on the importance of testing, patients in the LRG patient registry have higher rates of biomarker testing and survival than the general population. Our goal is to expand that reach exponentially (Let’s Get This Done in 2021!).
If you would like to talk to someone about mutational testing, please contact our Director of the Life Raft Group Patient Registry, Denisse Montoya at email@example.com